Skip to content

Restricted Cash at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$1.34M-37.0%
ALN
Alnylam PharmaceuticalsALNY
$1.64M-36.8%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$6.18M0.0%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$1.28M+59.1%
Alumis Inc. logo
Alumis Inc.ALMS
$86K-92.6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+31.9%
Enterprise value$1.07B+26.9%
P/S13.5×-10.1×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's restricted cash?
MeiraGTx Holdings plc (MGTX) reported restricted cash of $2.22M in Q1 2026.
How has MeiraGTx Holdings plc's restricted cash changed year-over-year?
MeiraGTx Holdings plc's restricted cash increased by 6.2% year-over-year, from $2.09M to $2.22M.
What is the long-term trend for MeiraGTx Holdings plc's restricted cash?
Over 2 years (2023 to 2025), MeiraGTx Holdings plc's restricted cash has grown at a 44.5% compound annual growth rate (CAGR), from $1.08M to $2.26M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.